Business
Diaceutics to attend Stifel Conference in NYC
Diaceutics to attend Stifel Conference in NYC.
About this update from Diaceutics Plc
[{"type":"text","content":"\n\nDiaceutics to attend Stifel and LSE 'Best of British' Conference in NYC\n \nBelfast and London, 30 November 2023 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical and biotech industry, announces that management will attend the Stifel 5th Annual 'Best of British' Discovery Conference at the London Stock Exchange's NYC offices on 13 December 2023.\n \nEnquiries: \n \n\n\n\n\nDiaceutics PLC \n\n\n\n\n\n\n\nPeter Keeling, Chief Executive Officer \n\n\n Tel: +44 (0)28 9040 6500 \n\n\n\n\nRyan Keeling, Chief Executive Officer Designate \n\n\[email protected] \n\n\n\n\nNick Roberts, Chief Financial Officer \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nStifel Nicolaus Europe Limited (Nomad & Broker) \n\n\nTel: +44 (0)20 7710 7600 \n\n\n\n\nBen Maddison \n\n\n\n\n\n\n\nNick Harland \n\n\n\n\n\n\n\nKate Hanshaw\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAlma Strategic Communications\n\n\nTel: +44(0)20 3405 0205 \n\n\n\n\nCaroline Forde \n\n\[email protected]\n\n\n\n\nMatthew Young\n\n\n\n\n\n\n\nKinvara Verdon\n\n\n\n\n\n\n\n \nAbout Diaceutics\nAt Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.\n \nWe provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®\n \n \n\n","length":5759,"tagName":"div"}]